SLLK, Control Peptide for TSP1 Inhibitor(TFA) HY-P0301A from MedChemExpress | Biocompare.com

Be the first to write a review!

Citations:

Supplier Page from
MedChemExpress for
SLLK, Control Peptide for TSP1 Inhibitor(TFA)

Description

SLLK, Control Peptide for TSP1 Inhibitor (TFA) is a control peptide for LSKL, which is a Thrombospondin (TSP-1) inhibitor

Product Specs
ItemSLLK, Control Peptide for TSP1 Inhibitor(TFA)
CompanyMedChemExpress
Price $72.00Supplier Page View Company Product Page
Catalog NumberHY-P0301A
Size1 mg
ApplicationsBioactivity, Structure and function analysis, ELISA, SDS-PAGE, Western blotting
Purity99.83%
TypeChemical
Molecular Weight573.6
FormulaC₂₃H₄₂F₃N₅O₈
Research AreaCancer

Add to Compare List

MedChemExpress

MedChemExpress

1 Deer Park Drive, Suite F

MONMOUTH JUNCTION, NJ 08852

United States

Phone: US Tel: 609-228-6898
US Fax: 609-228-5909
EU Tel: +4686500910

Email: sales@medchemexpress.com
eu.sales@MedChemExpress.com

Company Profile

Website: medchemexpress.com

(1) A peptide antagonist of thrombospondin-1 promotes abdominal aortic aneurysm progression in the angiotensin II-infused apolipoprotein-E-deficient mouseArteriosclerosis, thrombosis, and vascular biologyFebruary 1, 2015Krishna SM, Seto SW, Jose RJ, Biros E, Moran CS, Wang Y, Clancy P, Golledge J.

(2) Blockade of TSP1-dependent TGF-β activity reduces renal injury and proteinuria in a murine model of diabetic nephropathyThe American journal of pathologyJune 1, 2011Lu A, Miao M, Schoeb TR, Agarwal A, Murphy-Ullrich JE.

Be the First to Write a Review!